Table 2 Baseline demographical and clinical characteristics of the study patients according to NPS.
Variables | Naples Prognostic Score group | P-value | ||
|---|---|---|---|---|
Group 0 (N = 131) | Group 1 (N = 153) | Group 2 (N = 41) | ||
Age, years | 65.00 [56.00;69.50] | 67.00 [55.00;72.00] | 73.00 [65.00;79.00] | 0.001 |
Male gender | 63 (48.09%) | 71 (46.41%) | 23 (56.10%) | 0.543 |
Smoking | 62 (47.33%) | 78 (50.98%) | 17 (41.46%) | 0.533 |
BMI, kg/m2 | 25.80 [20.85;31.60] | 25.80 [20.50;28.90] | 25.10 [23.40;27.60] | 0.928 |
At admission | ||||
Respiratory rate, beats/min | 16.00 [15.00;21.00] | 16.00 [15.00;21.00] | 16.00 [15.00;18.00] | 0.762 |
Heart rate, beats/min | 84.00 [65.00;87.00] | 87.00 [65.00;96.00] | 99.00 [87.00;114.00] | < 0.001 |
Systolic blood pressure, mmHg | 143.00 [127.00;152.00] | 143.00 [127.00;151.00] | 137.00 [114.00;152.00] | 0.032 |
Co-morbidities | ||||
Chronic lung disease | 18 (13.74%) | 22 (14.38%) | 2 (4.88%) | 0.256 |
Diabetes mellitus | 8 (6.11%) | 12 (7.84%) | 7 (17.07%) | 0.103 |
Hypertension | 6 (4.58%) | 19 (12.42%) | 4 (9.76%) | 0.063 |
Heart failure | 3 (2.29%) | 5 (3.27%) | 5 (12.20%) | 0.035 |
Cerebrovascular disease | 13 (9.92%) | 10 (6.54%) | 1 (2.44%) | 0.272 |
Malignant tumor | 32 (24.43%) | 20 (13.07%) | 4 (9.76%) | 0.016 |
DVT history | 6 (4.58%) | 10 (6.54%) | 7 (17.07%) | 0.032 |
Localization of thrombosis in PCTA | ||||
Main pulmonary artery | 29 (22.14%) | 29 (18.95%) | 4 (9.76%) | 0.212 |
Lobar pulmonary artery | 42 (32.06%) | 31 (20.26%) | 8 (19.51%) | 0.05 |
Segmental pulmonary artery | 76 (58.02%) | 93 (60.78%) | 29 (70.73%) | 0.346 |
Subsegmental pulmonary artery | 47 (35.88%) | 41(26.80%) | 15(36.59%) | 0.319 |
Echocardiography parameters | ||||
Right ventricle dilatation | 3 (2.29%) | 7 (4.58%) | 8 (19.51%) | 0.001 |
LVEF, % | 59.00 [54.00;65.00] | 61.00 [55.00;63.00] | 57.00 [55.00;62.00] | 0.644 |
PASP, mmHg | 48.00 [44.00;56.00] | 48.00 [44.00;56.00] | 47.00 [44.00;58.00] | 0.884 |
Admission blood gas analysis | ||||
PH | 7.38 [7.35;7.43] | 7.38 [7.35;7.43] | 7.39 [7.35;7.54] | 0.101 |
PO2 ,mmHg | 76.00 [76.00;86.00] | 76.00 [76.00;87.00] | 77.00 [74.00;86.00] | 0.871 |
HCO3, mmol/L | 25.00 [21.00;26.00] | 24.00 [21.00;26.00] | 25.00 [22.00;26.00] | 0.983 |
Lactate, mmol/L | 3.10 [1.90;3.30] | 3.10 [1.90;3.60] | 2.80 [1.90;3.10] | 0.164 |
Laboratory parameters | ||||
D-Dimer, ng/mL | 3213.00 [1345.00;5432.00] | 2356.00 [1234.00;5412.00] | 1889.00 [1284.00;3503.00] | 0.165 |
Troponin I, ng/mL | 0.13 [0.08;0.17] | 0.12 [0.06;0.17] | 0.17 [0.08;0.21] | 0.205 |
BNP, pg/mL | 356.00 [124.00;453.00] | 356.00 [124.00;453.00] | 356.00 [124.00;678.00] | 0.339 |
White blood cell count,×109/L | 9.40 [7.25;10.20] | 9.40 [7.90;10.20] | 9.40 [8.40;10.20] | 0.934 |
Haemoglobin ,g/L | 123.00 [111.00;146.00] | 121.00 [106.00;143.00] | 123.00 [109.00;143.00] | 0.456 |
Platelet count,×109/L | 213.00 [134.00;256.00] | 218.00 [167.00;312.00] | 167.00 [134.00;256.00] | 0.083 |
Albumin, mg/dL | 3.95 [3.40;4.44] | 3.79 [3.15;4.91] | 3.13 [2.54;4.10] | < 0.001 |
Total cholesterol,mg/ dl | 189.00 [184.00;194.00] | 182.00 [185.00;194.00] | 173.00 [165.00;179.00] | 0.073 |
NLR | 3.36 [2.21;4.06] | 4.11 [2.49;4.46] | 5.56 [4.11;8.99] | 0.011 |
LMR | 4.65 [4.59;4.87] | 4.65 [4.02;4.87] | 3.69 [2.46;3.99] | 0.031 |